Date
|
Update
|
12 October 2023
|
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in late July 2024. These timings are based on a request from the company to reschedule the initial date set by NICE, in order to facilitate a suitably comprehensive and robust submission. |
24 July 2023
|
Stakeholder workshop |
25 May 2023 - 23 June 2023
|
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 5071 |
25 May 2023
|
In progress. Scoping commencing |
25 November 2022
|
As you will be aware, the Department for Health & Social Care has asked NICE to conduct an appraisal of Fezolinetant for untreated vasomotor symptoms associated with the menopause.
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in early December 2023. These timings are based on a request from the company to reschedule the initial date set by NICE, in order to facilitate a suitably comprehensive and robust submission. |
07 June 2022
|
Awaiting development. Status change linked to Topic Selection Decision being set to Selected |